NCT00092352已完成3 期
A Randomized, Placebo-Controlled, Parallel-Group, Double -Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients With Osteoarthritis of the Knee
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 395
- 主要终点
- Osteoarthritis (OA) of the knee as measured by Patient Global Assessment of Response to Therapy (PGART) and WOMAC VA 3.0 over 6 weeks of treatment.
研究概览
简要总结
The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of osteoarthritis of the knee.
详细描述
The duration of treatment is 6 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Osteoarthritis of the knee which requires treatment with medication for pain relief
排除标准
- •Any known allergy to the study drug
结局指标
主要结局
Osteoarthritis (OA) of the knee as measured by Patient Global Assessment of Response to Therapy (PGART) and WOMAC VA 3.0 over 6 weeks of treatment.
次要结局
- WOMAC Question #1 over 6 wks of treatment.
- OA of the knee as measured by PGART over 6 wks of treatment.
研究者
相似试验
已完成
3 期
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)OsteoarthritisNCT00092365Merck Sharp & Dohme LLC413
已完成
3 期
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)Postoperative PainNCT00092339Merck Sharp & Dohme LLC125
已完成
3 期
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)Postoperative PainNCT00092300Merck Sharp & Dohme LLC450
已完成
3 期
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)Postoperative PainNCT00092313Merck Sharp & Dohme LLC271
已完成
3 期
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)Postoperative PainNCT00092326Merck Sharp & Dohme LLC269